Use of Troponin as a predictor for cardiovascular diseases in patients with type 2 Diabetes Mellitus

Chiara Bellia, Mauro Lombardo, David Della-Morte

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


People with type 2 diabetes mellitus (T2DM) have two- to four-fold increased cardiovascular mortality in comparison to the general population. With the identification of new therapeutic targets and hypoglycemic drugs for T2DM, the need for a better stratification of CVD risk has emerged to select patients who may need intensive or specific treatment. At present, risk stratification is based on clinical, demographic, and biochemical factors. High sensitivity cardiac troponin (hs-cTn) increases after several ischemic and non-ischemic insults and it is considered a marker of myocardial injury. This review summarizes the main findings about hs-cTn utilization for risk stratification in people with T2DM and no clinical CVD. Several large observational studies have documented the association between hs-cTn and adverse cardiovascular outcomes in both the general population and in patients with T2DM. Lifestyle interventions, and particularly promotion of physical activity and adoption of healthy nutritional habits, have been associated to a significant benefit on hs-cTn release in the general population. Randomized controlled trials suggested that hypoglycemic, anti-hypertensive and lipid-lowering therapy may influence the degree of T2DM-induced cardiac injury. Besides these promising findings, the efficacy of an hs-cTn-based approach for CVD prevention in T2DM patients still requires more investigations.

Original languageEnglish (US)
Pages (from-to)54-61
Number of pages8
JournalClinica Chimica Acta
StatePublished - Aug 2020


  • Biomarkers
  • Cardiovascular diseases
  • Diabetes mellitus
  • Primary prevention
  • Risk factors
  • Troponin

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical


Dive into the research topics of 'Use of Troponin as a predictor for cardiovascular diseases in patients with type 2 Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this